» Articles » PMID: 26817845

Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2016 Jan 29
PMID 26817845
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine deaminases acting on double-stranded RNA (ADARs) catalyze the deamination of adenosine (A) to produce inosine (I) in double-stranded (ds) RNA structures, a process known as A-to-I RNA editing. dsRNA is an important trigger of innate immune responses, including interferon (IFN) production and action. We examined the role of A-to-I RNA editing by two ADARs, ADAR1 and ADAR2, in the sensing of self-RNA in the absence of pathogen infection, leading to activation of IFN-induced, RNA-mediated responses in mouse embryo fibroblasts. IFN treatment of Adar1(-/-) cells lacking both the p110 constitutive and p150 IFN-inducible ADAR1 proteins induced formation of stress granules, whereas neither wild-type (WT) nor Adar2(-/-) cells displayed a comparable stress granule response following IFN treatment. Phosphorylation of protein synthesis initiation factor eIF2α at serine 51 was increased in IFN-treated Adar1(-/-) cells but not in either WT or Adar2(-/-) cells following IFN treatment. Analysis by deep sequencing of mouse exonic loci containing A-to-I-editing sites revealed that the majority of editing in mouse embryo fibroblasts was carried out by ADAR1. IFN treatment increased editing in both WT and Adar2(-/-) cells but not in either Adar1(-/-) or Adar1(-/-) (p150) cells or Stat1(-/-) or Stat2(-/-) cells. Hyper-edited sites found in predicted duplex structures showed strand bias of editing for some RNAs. These results implicate ADAR1 p150 as the major A-to-I editor in mouse embryo fibroblasts, acting as a feedback suppressor of innate immune responses otherwise triggered by self-RNAs possessing regions of double-stranded character.

Citing Articles

inositol hexaphosphate pathways couple to RNA interference and pathogen defense.

Xu W, Sun Y, Breen P, Ruvkun G, Mao K Proc Natl Acad Sci U S A. 2024; 121(49):e2416982121.

PMID: 39602251 PMC: 11626161. DOI: 10.1073/pnas.2416982121.


Charting and probing the activity of ADARs in human development and cell-fate specification.

Dailamy A, Lyu W, Nourreddine S, Tong M, Rainaldi J, McDonald D Nat Commun. 2024; 15(1):9818.

PMID: 39537590 PMC: 11561244. DOI: 10.1038/s41467-024-53973-0.


A highly conserved A-to-I RNA editing event within the glutamate-gated chloride channel GluClα is necessary for olfactory-based behaviors in .

Zak H, Rozenfeld E, Levi M, Deng P, Gorelick D, Pozeilov H Sci Adv. 2024; 10(36):eadi9101.

PMID: 39231215 PMC: 11373593. DOI: 10.1126/sciadv.adi9101.


RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection.

Huang M, Mark A, Pham J, Vera K, Saravia-Butler A, Beheshti A PLoS One. 2024; 19(8):e0307450.

PMID: 39178184 PMC: 11343423. DOI: 10.1371/journal.pone.0307450.


RNA editing and immune control: from mechanism to therapy.

Hu S, Li J Curr Opin Genet Dev. 2024; 86:102195.

PMID: 38643591 PMC: 11162905. DOI: 10.1016/j.gde.2024.102195.


References
1.
Hartner J, Walkley C, Lu J, Orkin S . ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol. 2008; 10(1):109-15. PMC: 2701568. DOI: 10.1038/ni.1680. View

2.
Yoneyama M, Onomoto K, Jogi M, Akaboshi T, Fujita T . Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol. 2015; 32:48-53. DOI: 10.1016/j.coi.2014.12.012. View

3.
Ryter J, SCHULTZ S . Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA. EMBO J. 1998; 17(24):7505-13. PMC: 1171094. DOI: 10.1093/emboj/17.24.7505. View

4.
Bass B, Weintraub H . An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell. 1988; 55(6):1089-98. DOI: 10.1016/0092-8674(88)90253-x. View

5.
Langland J, Cameron J, Heck M, Jancovich J, Jacobs B . Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006; 119(1):100-10. DOI: 10.1016/j.virusres.2005.10.014. View